2011 to 2022 Saw Increase in STEMI Mortality in Young Adults
Medically reviewed by Drugs.com
via HealthDayTUESDAY, March 3, 2026 -- Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published online Feb. 26 in the Journal of the American Heart Association.
Mohan Satish, M.D., from New York-Presbyterian/Weill Cornell Medicine in New York City, and colleagues examined first acute myocardial infarction (AMI) hospitalizations among young adults aged 18 to 54 years from 2011 to 2022 in the United States, stratified by subtype and sex. The primary outcome was in-hospital mortality by first AMI-subtype; secondary outcomes included in-hospital complications.
Of the 945,977 weighted first AMI hospitalizations in young adults, 37.6 and 62.4 percent were STEMI and non-STEMI, respectively. The researchers found that across the study period, adjusted in-hospital mortality increased significantly for first STEMI (1.2 percent absolute increase) and was unchanged for first non-STEMI (0.2 percent absolute decrease). Higher in-hospital mortality was seen for young women than young men (STEMI: 3.1 versus 2.6 percent; non-STEMI: 1.0 versus 0.8 percent); they experienced similar in-hospital complications with lower receipt of cardiovascular procedures. More nontraditional than traditional risk factors were independently associated with higher odds of in-hospital mortality, regardless of sex.
"Improving heart attack outcomes in adults younger than age 55, particularly women, will require earlier risk identification and consideration of nontraditional risk factors to improve treatment," Satish said in a statement. "Future studies need to consider how nontraditional risk factors impart heart attack risk along with their impact on traditional risk factors."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-04 08:45
Read more
- Chinese Mind-Body Practice Can Lower Systolic BP in Adults With High Blood Pressure
- Johnson & Johnson Therapy Nipocalimab Granted U.S. FDA Fast Track Designation in Systemic Lupus Erythematosus (SLE)
- Study Suggests Cutting Sugar Before Age 2 Could Lower Heart Disease Risk
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Worsening of Overactive Bladder Seen in Patients Undergoing Gender-Affirming Vaginoplasty
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions